ESC 365 - Special considerations in the management of patients with AF undergoing ablation or cardioversion.

ESC Premium Access

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Session: Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Topic: Atrial fibrillation (AF)

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Sponsored by Bayer AG

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)

27 presentations

1 follower

4 more presentations in this session

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Professor R. Mehran (New York, US)

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Milan, IT)

Access the full session

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Speakers: Professor S. Hohnloser, Professor R. Mehran, Professor K. Fox, Doctor C. Ruff, Doctor R. Cappato

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Related content

Open Access

Management of ASCVD risk in apparently healthy people.

30 August 2021

ESC Premium Access

Prognostic value of ABCDE stress echocardiography

27 August 2021

Open Access

Optimizing SGLT2 inhibition: recent data.

29 June 2021

ESC 365 is supported by